RAS-targeted therapies: is the undruggable drugged?
نویسندگان
چکیده
منابع مشابه
Drugged driving: how much is too much?
Detecting impairment from cannabis is not as straightforward as detecting alcohol because of the complex nature of the drug and lack of conclusive research about the dose–effect of cannabis. The widely used breathalyzer test can accurately detect alcohol impairment using a breath sample because the amount of alcohol in exhaled air closely relates to the amount of alcohol in the blood, says Dr. ...
متن کاملA RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer.
Of the numerous oncogenes implicated in human cancer, the most common and perhaps the most elusive to target pharmacologically is RAS. Since the discovery of RAS in the 1960s, numerous studies have elucidated the mechanism of activity, regulation, and intracellular trafficking of the RAS gene products, and of its regulatory pathways. These pathways yielded druggable targets, such as farnesyltra...
متن کاملB cell targeted therapies
Although the precise pathogenesis of rheumatoid arthritis (RA) remains unclear, many cell populations, including monocytes, macrophages, endothelial cells, fibroblasts and B cells, participate in the inflammatory process. Ongoing research continues to evaluate the critical roles played by B cells in sustaining the chronic inflammatory process of RA. These findings have contributed to the develo...
متن کاملTargeted cancer therapies
With unprecedented understanding of molecular events underlying human cancer in this genomic era, a large number of drugs specifically targeting hypothesized oncogenic drivers to which tumors are potentially addicted to have been developed and continue to be developed. These targeted cancer therapies are being actively tested in clinical trials with mixed successes. This editorial provides an o...
متن کاملTargeted Therapies in Sarcomas: Challenging the Challenge
Sarcomas are a heterogeneous group of mesenchymal malignancies that very often lead to death. Nowadays, chemotherapy is the only available treatment for most sarcomas but there are few active drugs and clinical results still remain very poor. Thus, there is an imperious need to find new therapeutic alternatives in order to improve sarcoma patient's outcome. During the last years, there have bee...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Drug Discovery
سال: 2020
ISSN: 1474-1776,1474-1784
DOI: 10.1038/s41573-020-0068-6